Effectiveness, safety and feasibility of extended‐release naltrexone for opioid dependence: a 9‐month follow‐up to a 3‐month randomized trial.

Autor: Solli, Kristin Klemmetsby1 k.k.solli@medisin.uio.no, Latif, Zill‐e‐Huma2, Opheim, Arild3,4, Krajci, Peter5, Sharma‐Haase, Kamni1,6, Benth, Jūratė Šaltytė7,8, Tanum, Lars1,2, Kunoe, Nikolaj1
Zdroj: Addiction. Oct2018, Vol. 113 Issue 10, p1840-1849. 10p. 1 Diagram, 3 Charts, 2 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje